Commonwealth Equity Services, LLC Soligenix, Inc. Transaction History

Commonwealth Equity Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$1.7 - $2.61 $61,455 - $94,351	-36,150 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.36 - $2.26 $49,164 - $81,698	36,150 New	36,150 $76,000
Q4 2019 Feb 05, 2020	SELL	$0.87 - $1.45 $48,613 - $81,023	-55,878 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$0.72 - $1.31 $72 - $131	-100 Reduced 0.18%	55,878 $53,000
Q2 2019 Jul 19, 2019	BUY	$0.67 - $0.91 $2,010 - $2,730	3,000 Added 5.66%	55,978 $39,000
Q4 2018 Feb 11, 2019	BUY	$0.85 - $2.1 $5,607 - $13,853	6,597 Added 14.22%	52,978 $45,000
Q3 2018 Nov 06, 2018	BUY	$0.98 - $1.97 $45,453 - $91,370	46,381 New	46,381 $87,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $117M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.